Condition: Human Papilloma Virus · Cervical Intraepithelial Neoplasia · Cervical Cancer · Sponsor: Karolinska Institutet
The aim of the trial is to determine whether organized screening with primary HPV analysis provide higher cancer protection in the age group 23-29 years compared to primary cytology.
This description comes directly from the study's public registry record.
Joakim Dillner, MD, PhD · +46 (0) 72-468 24 60 · joakim.dillner@ki.se
Miriam Elfström, PhD · +46 (0) 70-381 62 77 · miriam.elfstrom@ki.se
Always discuss trial participation with your own doctor first.
| Region of Skåne | Lund, Skåne County, Sweden | Active Not Recruiting |
| Region Stockholm | Stockholm, Sweden | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05229679